Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,525 recalls · Class III, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class III · Low risk

Make Up Perfect ivory

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1106-2017
Class III · Low risk

Make Up Transparent terra

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1105-2017
Class III · Low risk

Make Up Perfect caramel

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1103-2017
Class III · Low risk

Make Up Transparent sand

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1102-2017
Class III · Low risk

Make Up Transparent pastel

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1101-2017
Class III · Low risk

Make Up Transparent ivory

Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Terminated Wrong potency / content Linde Eckstein Gmbh + Co KG D-1100-2017
Class III · Low risk

Pravastatin Sodium Tablets

Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-229-90 D-1038-2017
Class III · Low risk

Argatroban Injection

Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point

Terminated Impurity / degradation Hospira Inc., A Pfizer Company NDC 0409-1140-01 D-0980-2017
Class III · Low risk

Obagi-C Rx System C-Therapy Night Cream

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 62032-222-02 D-0998-2017
Class III · Low risk

Walgreens Daytime and Nighttime Cold & Flu

Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.

Terminated Labeling / mix-up L. Perrigo Company D-0925-2017
Class III · Low risk

G & W Clobetasol Propionate Ointment 0.05%

Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.

Terminated Impurity / degradation G & W Laboratories, Inc. NDC 0713-0656-15 D-0945-2017
Class III · Low risk

BuPROPion HCL Tablets

Failed Moisture Limits: Product tested out-of-specification for moisture content.

Terminated Failed specification Mckesson Packaging Services D-0928-2017

Recalls by year